GlassScriptPhysician profile
Lisa Ann Kopp
NPI 1821077322
$484.88
in general payments reported to CMS, 2019-2025
11 companies · $34.45 in 2025
The $34.45 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.21 · 2020: $31.06 · 2021: $247 · 2023: $95.55 · 2024: $47.62 · 2025: $34.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $202.19 | 2021-2023 | |
| Novo Nordisk INC | $98.46 | 2021-2025 | Ozempic, Wegovy |
| Abbott Laboratories | $48.51 | 2023-2024 | Freestyle Libre 3 |
| Pfizer INC. | $29.40 | 2020-2024 | |
| Lilly USA, LLC | $17.76 | 2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $17.08 | 2024 | Breztri |
| Allergan, INC. | $16.59 | 2020 | |
| Lupin INC. | $15.64 | 2019 | |
| Amgen INC. | $13.57 | 2019 | |
| Astellas Pharma US INC | $13.10 | 2023 | Veozah |
| Dexcom, INC. | $12.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Kopp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.